Use of venetoclax in transplant conditioning regimen shows promise in myeloid cancers
Trial is important step toward determining if this drug add-on can reduce risk of relapse in these patients
Read moreHEALTH PROFESSIONALS
Avila receives funding for teacher preparation in visual impairment
Kimberly R. Avila, Visual Impairment Consortium and Assistant Professor, College of Education and Human Development, received $299,553 from the U.S.
Read moreReducing risk in AI and machine learning-based medical technology
To manage the risks, regulators should focus particularly on continuous monitoring and risk assessment, and less on planning for future algorithm changes
Read moreUsing lungs from increased-risk donors expands donor pool, maintains current survival rates
Currently, there are nearly 1,500 people waiting for a lung transplant in the US
Read moreUsing lungs from increased-risk donors expands donor pool, maintains current survival rates
Currently, there are nearly 1,500 people waiting for a lung transplant in the US
Read moreIntroducing peanuts and eggs early can prevent food allergies in high risk infants
Research undertaken by King’s College London and St George’s, University of London has found that introducing certain foods early to
Read moreBone and muscle health can ‘make or break’ care as we age
Experts at a prestigious medical conference hosted by the American Geriatrics Society (AGS) and funded by the National Institutes of
Read moreIntroducing peanuts and eggs early can prevent food allergies in high risk infants
Research undertaken by King’s College London and St George’s, University of London has found that introducing certain foods early to
Read moreBone and muscle health can ‘make or break’ care as we age
Experts at a prestigious medical conference hosted by the American Geriatrics Society (AGS) and funded by the National Institutes of
Read moreMajor epilepsy study offers much-needed answers on 3 lifesaving seizure drugs
Researchers urge doctors to increase dose of commonly used drug
Read moreOlaparib becomes first gene-targeted medicine to show benefits in prostate cancer
A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some
Read moreFirearms, by far, the most lethal method for suicide
Embargoed news from Annals of Internal Medicine
Read more